SCHEMBL6131965

SCHEMBL6131965

Nc1ccc[c]c1-c1ccc(F)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.35
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 4/20 0.32
ALOX5 P09917 1/20 0.32
RAB9A P51151 1/20 0.32
ADORA2A P29274 2/20 0.32
TDO2 P48775 1/20 0.32
HPGD P15428 3/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2C19 P33261 2/20 0.31
KDM4E B2RXH2 2/20 0.31
HSD17B10 Q99714 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
HTT P42858 2/20 0.31
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607475 0.81 CYP3A4 (0.46) CYP3A4ALOX15CASP1CASP7SMN1; SMN2
SCHEMBL150096 0.79 MAOB (0.32) RAB9AMAOB
SCHEMBL5014600 0.78 PTGS2 (0.39) SMN1; SMN2ALDH1A1RAB9ATDO2PTGS1
SCHEMBL2012242 0.76 MAPK1 (0.38) SMN1; SMN2RAB9AHSD17B10HTTTSHR
SCHEMBL9650164 0.76 NPC1 (0.35) CYP3A4ALOX15SMN1; SMN2ALDH1A1ALOX5
SCHEMBL2011907 0.76 KDM4E (0.38) ALDH1A1RAB9AKDM4EHSD17B10TSHR
SCHEMBL9646646 0.76 GRM2 (0.31) CYP3A4ALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL7683321 0.74 HTT (0.38) SMN1; SMN2ALDH1A1HTTMEN1KMT2A
SCHEMBL7454339 0.73 CA12 (0.38) SMN1; SMN2ALDH1A1RAB9ATDO2PDGFRB
SCHEMBL2433532 0.73 NR1H2 (0.35) CYP3A4ALOX15ALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP claimed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP claimed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO claimed